As a global organization that is fuelled by research and a commitment to advancing science, Roche recognizes the value of bringing innovation to patients who may not have other treatment options available to them. Our commitment to the future of medicine hinges on our ability to invest and reinvest in countries, markets and communities that offer fertile ground for this research.
The Roche Global Product Development site in Mississauga is one of five product development sites within the Roche global community. In August 2011, Roche invested more than $190 million into expanding the Mississauga site. In this time, the site has grown from approximately 60 employees to more than 400 employees with highly skilled and specialized roles, including a presence in our global biometrics, regulatory, and clinical operations functions. These colleagues contribute to all phases of
In 2017, Roche invested over $52 million in